Cargando…
Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects
Pancreatic cancer (PC) is the fourth leading cause of cancer death, with a median survival of 6 months and a dismal 5-year survival rate of 3—5%, a figure which has remained relatively unchanged over the past 25 years. PC is one of the most difficult diseases to treat due to late initial diagnosis a...
Autores principales: | Iovanna, Juan, Neira, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763904/ https://www.ncbi.nlm.nih.gov/pubmed/20890586 http://dx.doi.org/10.1100/tsw.2010.184 |
Ejemplares similares
-
Cancer Chemoprevention
por: Amin, Amr, et al.
Publicado: (2012) -
The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention
por: Karamouzis, Michalis V., et al.
Publicado: (2007) -
Current and Future Cancer Chemoprevention Strategies
por: Santibanez, Juan F., et al.
Publicado: (2023) -
New molecular aspects in pathogenesis and progression of pancreatic cancer
por: Büchler, Peter, et al.
Publicado: (2003) -
Biochemical Aspects of Pancreatitis
por: Busch, Harris
Publicado: (1957)